Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 83
Drug Discovery 77
Optical 72
Optical Disorders Drugs 69
Immune Disorders Drugs 68
Cardiovascular Drugs 46
Musculoskeletal Disorders Drugs 38
Biopharmaceuticals 36
Dermatological Drugs 35
Biotechnology 30
Genomics 28
Pharmaceuticals 23
Clinical Trials 23
Endocrine and Metabolic Disorders Drugs 23
Skin Cancer Drugs 21
Central Nervous System Drugs 19
Infectious Diseases Drugs 17
Allergy and Immunology 16
Respiratory Drugs 16
Infusions and Injectables 14
Drugs by Therapeutic Area 13
Gastrointestinal Drugs 13
Allergy Drugs 13
Lung Cancer Drugs 11
Oncology 10
Dermatology 9
Hematological Drugs 9
Leukemia Drugs 8
Needles and Syringes 8
Asthma Drugs 8
Diagnostics 7
Biosimilars and Biosuperiors 7
Pharmaceutical Manufacturing 7
Analgesics 6
Enzymes 6
Prostate Cancer Drugs 5
Ovarian Cancer Drugs 5
Transdermal and Transmucosal Drug Delivery 5
Liver and Kidney Disorders Drugs 5
Company Reports 4
Therapeutic Area 4
Pulmonary Medicine 4
Lymphoma Drugs 4
Cardiovascular Devices 4
Drug Delivery 4
Vaccines 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Colon Cancer Drugs 3
Proteomics 3
Laboratory Equipment 3
Pediatrics 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Healthcare Services 2
Pharmacoeconomics 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Cardiology 2
Endocrinology 2
Neurology 1
Hepatology 1
Generic Drugs 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



280 reviews

671 Results (Page 18 of 34)
- Relevance
  Sort by

Light Activated Therapies Market: Focus on Photodynamic Therapies, Photoimmunotherapies and Photothermal Therapies - Distribution by Target Indications, Key Players and Geographies: Industry Trends and Global Forecasts, 2021-2030

 Report
September 2021
140 Pages
Global

From

€4289EUR$4,799USD£3,739GBP

Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
85 Pages
Global

From

€3128EUR$3,500USD£2,727GBP

Allogeneic Stem Cell Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

 Report
November 2023
110 Pages
Global

From

€4022EUR$4,500USD£3,506GBP

Basal Cell Neoplasms - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1788EUR$2,000USD£1,558GBP

Multiple Myeloma Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4013EUR$4,490USD£3,498GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Head and Neck Squamous Cell Carcinoma - Global Strategic Business Report

 Report
August 2025
474 Pages
Global

From

€5228EUR$5,850USD£4,557GBP

Metastatic Lung Adenocarcinoma Treatment - Global Strategic Business Report

 Report
August 2025
286 Pages
Global

From

€5228EUR$5,850USD£4,557GBP

Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
4115 Pages
Global

From

€2234EUR$2,500USD£1,948GBP

Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
417 Pages
Global

From

€1788EUR$2,000USD£1,558GBP

Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
1834 Pages
Global

From

€2234EUR$2,500USD£1,948GBP

Ebola Drugs and Vaccines - Global Strategic Business Report

 Report
August 2025
485 Pages
Global

From

€5228EUR$5,850USD£4,557GBP

Drug Manufacturing Sector Scorecard - Thematic Intelligence

 Report
October 2022
23 Pages
Global

From

€1743EUR$1,950USD£1,519GBP

Multiple Myeloma - Market Insight, Epidemiology, and Market Forecast - 2034

 Report
April 2025
200 Pages
Global

From

€7105EUR$7,950USD£6,193GBP

$Refractory Multiple Myeloma- Pipeline Insight, 2025 - Product Thumbnail Image$

Refractory Multiple Myeloma- Pipeline Insight, 2025

 Clinical Trials
April 2025
180 Pages
Global

From

€2681EUR$3,000USD£2,337GBP

Glucagon-like Peptide 1 Global Market Report 2025

 Report
July 2025
250 Pages
Global

From

€4013EUR$4,490USD£3,498GBP

Waldenstrom Macroglobulinemia - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7105EUR$7,950USD£6,193GBP

Follicular Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7105EUR$7,950USD£6,193GBP

Optic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
62 Pages
Global

From

€1788EUR$2,000USD£1,558GBP

Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
925 Pages
Global

From

€2234EUR$2,500USD£1,948GBP

Non-small Cell Lung Cancer Drugs Market 2023-2027

 Report
May 2023
167 Pages
Global

From

€2234EUR$2,500USD£1,948GBP

671 Results (Page 18 of 34)
- 1
- 16
- 17
- 18
- 19
- 20

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.